Stock Taper
SCREENER COMPARE ANY 2 STOCKS
OSTX
OS THERAPIES INCORPORATED
AMEX
$1.59
▲ UP 0.63% (0.01)

KEY STATISTICS

Market Cap$72.41 M
52w High$2.54
52w Low$1.15
Dividend Yield—
Frequency—
P/E-1.56
Volume362.37K
Shares Out.45.54M

COMPANY

LEADERSHIP

Paul A. Romness
CHIEF EXECUTIVE
Paul A. Romness

COMPENSATION 2026

Salary$480,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$1,942,168

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 1, 2024
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
5

UPCOMING EARNINGS

DateNov 13, 2026
DayFriday
Rev. Est.$1.00M
NOV
13
FRI

PRICE

$1.59 ▲ UP 0.63% (+$0.01)
$1.58$1.60$1.639:33 AM10:37 AM11:42 AM12:46 PM1:50 PM2:55 PM3:59 PM1.59

About OS Therapies Incorporated

https://ostherapies.com ↗

OS Therapies Incorporated, founded in 2018 in Rockville, Maryland, is a clinical-stage biopharmaceutical company developing treatments for osteosarcoma and solid tumors, including OST-HER2 immunotherapy and OST-tADC antibody-drug conjugates.

INDUSTRY

Biotechnology

A PRODUCT OS THERAPIES INCORPORATED IS KNOWN FOR

OST-HER2 (daznelimgene lisbac)
OST-HER2 (daznelimgene lisbac)

OST-HER2 is a clinical-stage, off-the-shelf immunotherapy using genetically modified Listeria to target HER2-positive solid tumors, with FDA filings for a Biologics License Application in early 2026.

COMPETITORS

COMPETITOR
AZN COMPARE
GSK COMPARE
MGNX COMPARE
PFE COMPARE
ZYME COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
12
LISTED HERE
2
RANKED BY POSITION SIZE
VTS.AX
0.00% · 416.1K
IWC
0.01% · 111.9K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
6.60%
HOLDERS
39
TOP 12 OF 39 · RANKED BY POSITION SIZE
Vanguard Group Inc
540.4K sh · $756.59K
Susquehanna International Group, Llp
448.7K sh · $632.72K
Cm Management, LLC
400.0K sh · $760K
Ubs Group AG
348.7K sh · $491.64K
Geode Capital Management, LLC
301.8K sh · $573.41K
Howard Financial Services, Ltd.
248.0K sh · $471.2K
Blackrock, Inc.
242.5K sh · $460.71K
State Street Corp
120.1K sh · $228.19K
Marshall Wace, Llp
109.9K sh · $153.93K
Two Sigma Investments, LP
87.5K sh · $122.55K
Hightower Advisors, LLC
85.5K sh · $162.54K
Northern Trust Corp
71.3K sh · $99.83K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR:
EAGLE CRAIG
— · —
2026-07-01
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Romness Paul A.
Purchase · 500.0K shares
2024-12-05
★
OFFICER: SEE REMARKS
PETIT ROBERT
Purchase · 100.0K shares
2026-01-22
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Romness Paul A.
Purchase · 1.0M shares
2026-01-22

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
2 GRADES IN THE LAST 12 MONTHS
Lake Street BUY D. Boral Capital BUY

SECTORS PEERS

PEERPRICE
ADAG$4.02COMPARE
EQ$2.31COMPARE
SPRB$51.58COMPARE
OTLK$0.65COMPARE
NRXP$3.56COMPARE
INKT$12.20COMPARE
HOWL$0.87COMPARE
CRVO$2.62COMPARE